All lobbying filings

MONUMENT ADVOCACY

Lobbying for PHRMA

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$90,000

What the client paid this registrant for the period.

Official filing document

Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Trade (domestic/foreign)

Issues related to intellectual property protection, enforcement, and market access within trade negotiations; supply chain management; China; Issues related to global health; and issues related to tariffs.

Foreign Relations

Issues related to intellectual property protection, enforcement, and market access within trade negotiations; supply chain management; China; issues related to global health; and issues related to tariffs.

Health Issues

Medicare Part D, Medicare Part B Issues, Importation of Drugs; H.R. 1, the One Big Beautiful Bill Act; H.R. 1492, S. 832, the EPIC Act; Medicare IRA implementation, Drug Premium Stabilization Program. Drug pricing, reimbursement and coverage related to MFN including CMMI models, 340B, IRA maximum fair price, ASP. PBM Reform included in H.R. 7194, the Consolidated Appropriations Act, the Department of Labor proposed PBM rule. Affordability and patient access issues; EPIC

Bills named in this filing 4

H.R. 1
One Big Beautiful Bill Act
H.R. 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
S. 832
EPIC Act of 2025
H.R. 7194
Nicholas Dockery Medal of Honor Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.